NOX4 and diabetes mellitus: Having highlighted NOX4 signalling as a likely important regulator of angiogenic response in healthy CB-ECFCs exposed to experimental diabetes, we investigated whether migratory and tubulogenic function could be rescued by NOX4OE in this setting.